Skip to main content

Reata Pharmaceuticals Inc

RETADelisted Sep 26, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001358762

Reata Pharmaceuticals Inc was delisted on Sep 26, 2023; its insiders filed their last Form 4 on Sep 28, 2023; 214 institutions reported holding it in 13F filings for Q2 2023, worth $3.21B in total; no superinvestor held it.

13F holders, Q2 2023

Institutional positions in Reata Pharmaceuticals Inc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

RETA is no longer listed, so this page shows Q2 2023. 13F filings for later quarters list far fewer holders.

Institutional holders
214
+10 vs. Q1 2023
Shares held
31.5M
+3.11M (+10.9%) vs. Q1 2023
Total value
$3.21B
+$629.4M (+24.4%) vs. Q1 2023
New holders
43
73 more added
Sold out
33
62 more reduced

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RETA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 214 institutions
Q1 2021: 201 institutionsQ2 2021: 195 institutionsQ3 2021: 183 institutionsQ4 2021: 151 institutionsQ1 2022: 149 institutionsQ2 2022: 147 institutionsQ3 2022: 159 institutionsQ4 2022: 168 institutionsQ1 2023: 205 institutionsQ2 2023: 214 institutionsQ3 2023: 2 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $3.21B
Q1 2021: $2.52BQ2 2021: $3.76BQ3 2021: $2.69BQ4 2021: $704.3MQ1 2022: $884.1MQ2 2022: $841.1MQ3 2022: $706.1MQ4 2022: $1.14BQ1 2023: $2.58BQ2 2023: $3.21BQ3 2023: $2.98MQ4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding RETA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20232$2.98M
Q2 2023214$3.21B
Q1 2023205$2.58B
Q4 2022168$1.14B
Q3 2022159$706.1M
Q2 2022147$841.1M
Q1 2022149$884.1M
Q4 2021151$704.3M
Q3 2021183$2.69B
Q2 2021195$3.76B
Q1 2021201$2.52B

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Reata Pharmaceuticals Inc; share changes are against Q1 2023.

Institutions holding RETA in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Parallel Advisors, LLC25$2.55K0.00%00.0%Unchanged
Missouri Trust & Investment Co20$2.04K0.00%00.0%Unchanged
Harbour Investments, Inc.9$9180.00%00.0%Unchanged
Global Retirement Partners, LLC6$6120.00%00.0%Unchanged
Colonial Trust Advisors5$5100.00%00.0%Unchanged
Versant Capital Management, Inc5$5100.00%+5New
NewSquare Capital LLC4$4080.00%00.0%Unchanged
Optimum Investment Advisors2$2040.00%00.0%Unchanged
JFS Wealth Advisors, LLC2$2040.00%+2New
Disciplined Investments, LLC2$2040.00%+2New
SJS Investment Consulting Inc.2$2040.00%+2New
AdvisorNet Financial, Inc1$1020.00%+1New
Sofos Investments, Inc.102$500.00%+11+12.1%Added
Covestor Ltd2$00.00%−1−33.3%Reduced
Deep Track Capital, LP0$00.00%−729,000−100.0%Sold out
Assenagon Asset Management S.A.0$00.00%−347,961−100.0%Sold out
683 Capital Management, LLC0$00.00%−60,000−100.0%Sold out
Brookfield Asset Management Inc.0$00.00%−55,201−100.0%Sold out
Artia Global Partners LP0$00.00%−40,000−100.0%Sold out
CI Private Wealth, LLC0$00.00%−38,940−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−34,946−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−31,200−100.0%Sold out
Group One Trading, L.P.0$00.00%−24,376−100.0%Sold out
Squarepoint Ops LLC0$00.00%−23,769−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−21,760−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−16,154−100.0%Sold out
Keel Point, LLC0$00.00%−14,446−100.0%Sold out
Winton Group Ltd0$00.00%−10,882−100.0%Sold out
HAP Trading, LLC0$00.00%−10,319−100.0%Sold out
Sphera Funds Management Ltd.0$00.00%−7,689−100.0%Sold out
Ergoteles LLC0$00.00%−6,859−100.0%Sold out
Thrivent Financial for Lutherans0$00.00%−6,819−100.0%Sold out
Quantbot Technologies LP0$00.00%−5,952−100.0%Sold out
Raymond James Financial Services Advisors, Inc.0$00.00%−5,396−100.0%Sold out
Candriam Luxembourg S.C.A.0$00.00%−5,377−100.0%Sold out
Ameritas Advisory Services, LLC0$00.00%−3,908−100.0%Sold out
Quantamental Technologies LLC0$00.00%−3,553−100.0%Sold out
Acadian Asset Management LLC0$00.00%−3,159−100.0%Sold out
AXA S.A.0$00.00%−2,700−100.0%Sold out
International Assets Investment Management, LLC0$00.00%−385−100.0%Sold out
Belpointe Asset Management LLC0$00.00%−311−100.0%Sold out
Milestone Investment Advisors LLC0$00.00%−203−100.0%Sold out
Advisory Services Network, LLC0$00.00%−62−100.0%Sold out
Parallax Volatility Advisers, L.P.0$00.00%−48−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−39−100.0%Sold out
Bokf, NA0$00.00%−25−100.0%Sold out
Ellevest, Inc.0$00.00%−15−100.0%Sold out
Stonnington Group, LLC––––Not filed